USFDA grants orphan drug and pediatric exclusivities for Cresemba for aspergillosis and mucormycosis in children
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
BHL will undertake the development and supply of these molecules
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Subscribe To Our Newsletter & Stay Updated